Literature DB >> 31668314

Mutations in the Antioxidant KEAP1/NRF2 Pathway Define an Aggressive Subset of NSCLC Resistant to Conventional Treatments.

Ernest Nadal1, Ramon Palmero2, Cristina Muñoz-Pinedo3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31668314     DOI： 10.1016/j.jtho.2019.08.005

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  6 in total

1.  Eating away T cell responses in lung cancer.

Authors:  Roberto Ferrara; Luca Roz
Journal:  J Exp Med       Date:  2022-10-10       Impact factor: 17.579

2.  Antarctic Krill Oil Attenuates Oxidative Stress via the KEAP1-NRF2 Signaling in Patients with Coronary Heart Disease.

Authors:  Chengfei Wen; Mi Jiang; Weixin Huang; Shumei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-07       Impact factor: 2.629

3.  PDCD4 inhibits lung tumorigenesis by the suppressing p62-Nrf2 signaling pathway and upregulating Keap1 expression.

Authors:  Soon-Kyung Hwang; Yun-Jeong Jeong; Young-Chae Chang
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

4.  KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials.

Authors:  Hongyuan Zhu; Daipeng Xie; Yunfang Yu; Lintong Yao; Bin Xu; Luyu Huang; Shaowei Wu; Fasheng Li; Yating Zheng; Xinyi Liu; Wenzhuan Xie; Mengli Huang; Hao Li; Shaopeng Zheng; Dongkun Zhang; Guibin Qiao; Lawrence W C Chan; Haiyu Zhou
Journal:  Front Oncol       Date:  2021-07-26       Impact factor: 6.244

5.  Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome.

Authors:  Alberto Pavan; Andrea Boscolo Bragadin; Lorenzo Calvetti; Alessandra Ferro; Elisabetta Zulato; Ilaria Attili; Giorgia Nardo; Alessandro Dal Maso; Stefano Frega; Andrea Giovanni Menin; Matteo Fassan; Fiorella Calabrese; Giulia Pasello; Valentina Guarneri; Giuseppe Aprile; PierFranco Conte; Rafael Rosell; Stefano Indraccolo; Laura Bonanno
Journal:  Transl Lung Cancer Res       Date:  2021-01

Review 6.  NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis.

Authors:  Holly Robertson; Albena T Dinkova-Kostova; John D Hayes
Journal:  Cancers (Basel)       Date:  2020-12-02       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.